Statement regarding Olivier Bohuon

About this update from Smith & Nephew Plc

RNS Number : 5485N Smith & Nephew Plc 01 February 2016     Statement regarding Olivier Bohuon   1 February 2016     Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces that Olivier Bohuon, Chief Executive Officer, has been diagnosed with a highly treatable form of cancer. Olivier will remain Chief Executive Officer and be actively involved in running the Company through much of his treatment period, which will begin later this month. The treatment will include chemotherapy, and is expected to be completed by late autumn.   The Board has approved provisional governance procedures to ensure the effective operation of Smith & Nephew during the treatment period, including Chairman Roberto Quarta providing executive oversight if required.   Roberto Quarta, Chairman of Smith & Nephew, said, "Olivier has set a clear strategy that is invigorating Smith & Nephew's growth profile. I am confident that Olivier and his team will continue to execute the plan successfully. Our thoughts are with him as he undergoes treatment."   Olivier will present Smith & Nephew's Full Year and Q4 results on Thursday 4 February 2016 as normal.   Enquiries   Investors Ingeborg Øie Smith & Nephew   +44 (0) 20 7960 2285   Financial Media Charles Reynolds Smith & Nephew +44 (0) 20 7401 7646   Ben Atwell / Matthew Cole FTI Strategic Consulting   +44 (0) 20 3727 1000   About Smith & Nephew Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries. Annual sales in 2014 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).   For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com   Forward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our pro...

View stock analysis, news, and events for Smith & Nephew Plc